{
    "root": "212141a3-fffd-49e0-96d5-57cc921a99d1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Phenytoin",
    "value": "20241224",
    "ingredients": [
        {
            "name": "PHENYTOIN",
            "code": "6158TKW0C5"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED",
            "code": "K679OBS311"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "MAGNESIUM ALUMINUM SILICATE",
            "code": "6M3P64V0NC"
        },
        {
            "name": "POLYSORBATE 40",
            "code": "STI11B5A2X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "VANILLIN",
            "code": "CHI530446X"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        }
    ],
    "indications": "phenytoin indicated treatment tonic-clonic ( grand mal ) psychomotor ( temporal lobe ) seizures .",
    "contraindications": "• adult starting dose patients received previous treatment 5 ml three times daily , dose adjustments necessary , 25 ml daily . ( 2.2 ) • pediatric starting dose 5 mg/kg/day two three equally divided doses , adjustments necessary , maximum 300 mg daily . maintenance 4 8 mg/kg/day . ( 2.3 ) • serum blood level determinations may necessary optimal adjustments—the clinically effective serum total concentration 10 20 mcg/ml ( unbound phenytoin concentration 1 2 mcg/ml ) . ( 2.1 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "phenytoin contraindicated patients : •a history hypersensitivity phenytoin , inactive ingredients , hydantoins [ ( 5.5 ) ] . included angioedema . •a history prior acute hepatotoxicity attributable phenytoin [ ( 5.8 ) ] . •coadministration delavirdine potential loss virologic response possible resistance delavirdine class non-nucleoside reverse transcriptase inhibitors .",
    "indications_original": "Phenytoin is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures.",
    "contraindications_original": "• Adult starting dose in patients who have received no previous treatment is 5 mL three times daily, with dose adjustments as necessary, up to 25 mL daily. ( 2.2 ) • Pediatric starting dose is 5 mg/kg/day in two to three equally divided doses, with dosage adjustments as necessary, up to a maximum of 300 mg daily. Maintenance dosage is 4 to 8 mg/kg/day. ( 2.3 ) • Serum blood level determinations may be necessary for optimal dosage adjustments—the clinically effective serum total concentration is 10 to 20 mcg/mL (unbound phenytoin concentration is 1 to 2 mcg/mL). ( 2.1 )",
    "adverseReactions_original": "Phenytoin is contraindicated in patients with: \n                  \n                     \n                        •A history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins [see Warnings and Precautions (5.5)]. Reactions have included angioedema.\n                     \n                        •A history of prior acute hepatotoxicity attributable to phenytoin [see Warnings and Precautions (5.8)].\n                     \n                        •Coadministration with delavirdine because of the potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors."
}